Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:605016's EV-to-EBITDA is ranked worse than 72.02% of 1701
companies
in the Consumer Packaged Goods industry
Industry Median: 8.99
vs SHSE:605016: 14.55
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shandong Bailong Chuangyuan Bio-Tech Co's PE Ratio (TTM) for today is calculated as:
Shandong Bailong Chuangyuan Bio-Tech Co's share price for today is ¥20.93.
Shandong Bailong Chuangyuan Bio-Tech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.975.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Bailong Chuangyuan Bio-Tech Co EV-to-EBITDA Chart
Shandong Bailong Chuangyuan Bio-Tech Co Annual Data
For the Packaged Foods subindustry, Shandong Bailong Chuangyuan Bio-Tech Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Bailong Chuangyuan Bio-Tech Co EV-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Shandong Bailong Chuangyuan Bio-Tech Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Shandong Bailong Chuangyuan Bio-Tech Co's EV-to-EBITDA falls into.
Shandong Bailong Chuangyuan Bio-Tech Co's current Enterprise Value is ¥8,596 Mil.
Shandong Bailong Chuangyuan Bio-Tech Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥591 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) has a EV-to-EBITDA of 14.55 as of Sep. 21, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Shandong Bailong Chuangyuan Bio-Tech Co. This is 25% below median its historical median of 19.33. Over the past decade, Shandong Bailong Chuangyuan Bio-Tech Co's EV-to-EBITDA has ranged from 10.58 to 35.40. According to the industry distribution chart, Shandong Bailong Chuangyuan Bio-Tech Co ranks #1225 out of 1701 companies in the Consumer Packaged Goods industry, placing it in the top 72%.
Is Shandong Bailong Chuangyuan Bio-Tech Co's EV-to-EBITDA too high?
Shandong Bailong Chuangyuan Bio-Tech Co's current EV-to-EBITDA of 14.55 is 25% below median its 10-year median of 19.33. Over the past 10 years, this metric has ranged from a low of 10.58 to a high of 35.40. The Consumer Packaged Goods industry median EV-to-EBITDA is 8.99. Shandong Bailong Chuangyuan Bio-Tech Co's value of 14.55 is 61.8% above this industry median. Based on the distribution chart, Shandong Bailong Chuangyuan Bio-Tech Co ranks #1225 out of 1701 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Shandong Bailong Chuangyuan Bio-Tech Co has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Bailong Chuangyuan Bio-Tech Co's EV-to-EBITDA compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Shandong Bailong Chuangyuan Bio-Tech Co ranks #1225 out of 1701 companies for EV-to-EBITDA. This places Shandong Bailong Chuangyuan Bio-Tech Co in the lower half of its industry. The industry median EV-to-EBITDA is 8.99. Shandong Bailong Chuangyuan Bio-Tech Co's value of 14.55 is 61.8% above this benchmark. Historically, Shandong Bailong Chuangyuan Bio-Tech Co's own EV-to-EBITDA has ranged from 10.58 to 35.40 over the past decade. While the company's 10-year median is 19.33 vs. the industry median of 8.99, Shandong Bailong Chuangyuan Bio-Tech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Consumer Packaged Goods company?
The median EV-to-EBITDA among Consumer Packaged Goods companies is 8.99, based on 1,701 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Bailong Chuangyuan Bio-Tech Co's current EV-to-EBITDA of 14.55 is 61.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Shandong Bailong Chuangyuan Bio-Tech Co. For the Consumer Packaged Goods industry, the median EV-to-EBITDA is 8.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Bailong Chuangyuan Bio-Tech Co's current EV-to-EBITDA is 14.55, which is 25% below median its own 10-year median of 19.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Bailong Chuangyuan Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥26.52, compared to a current price of ¥20.93 — trading 21.1% below its estimated fair value. The current EV-to-EBITDA is 14.55, which is 25% below median its 10-year median of 19.33 and 61.8% above the Consumer Packaged Goods industry median of 8.99. Shandong Bailong Chuangyuan Bio-Tech Co's overall GF Score™ is 97/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016), the current EV-to-EBITDA is 14.55 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Bailong Chuangyuan Bio-Tech Co stock appears to be undervalued.
The current stock price of ¥20.93 is trading 21.1% below its estimated GF Value™ of ¥26.52.
GuruFocus considers Shandong Bailong Chuangyuan Bio-Tech Co to be Modestly Undervalued.
Key valuation signals for SHSE:605016:
EV-to-EBITDA: 14.55 (25% below median its 10-year median of 19.33)
GF Value™: ¥26.52 vs. price of ¥20.93 (21.1% below fair value)
Industry Position: 61.8% above the Consumer Packaged Goods median (#1225 of 1701)
No single metric tells the full story. See the SHSE:605016 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Bailong Chuangyuan Bio-Tech Co Ltd is engaged in the research and development, production and sales of prebiotic series products, dietary fiber series products, other starch sugar (alcohol) series products and healthy sweetener products.
97GF Score
Get the complete analysis for SHSE:605016
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605016 has been successfully added to your 
